| Date | Time | Source | Announcement |
|---|---|---|---|
| 31 Aug 2007 | 03:39 PM | Holding(s) in Company | |
| 31 Aug 2007 | 10:26 AM | TVR Update | |
| 30 Aug 2007 | 09:10 AM | Holding(s) in Company | |
| 07 Aug 2007 | 07:00 AM | Notice of Results | |
| 03 Aug 2007 | 04:33 PM | Holding(s) in Company | |
| 02 Aug 2007 | 03:38 PM | Holding(s) in Company | |
| 02 Aug 2007 | 07:02 AM | Phase II Clinical Trial Data | |
| 31 Jul 2007 | 03:05 PM | Total Voting Rights | |
| 25 Jul 2007 | 07:00 AM | DSMB Interim Analysis-TroVax | |
| 06 Jul 2007 | 07:00 AM | License Agreement | |
| 02 Jul 2007 | 07:00 AM | Lentivector Licence | |
| 29 Jun 2007 | 04:17 PM | Total Voting Rights | |
| 28 Jun 2007 | 12:39 PM | Holding(s) in Company | |
| 28 Jun 2007 | 12:29 PM | Notification of Interest | |
| 22 Jun 2007 | 12:43 PM | Viragen Update | |
| 18 Jun 2007 | 07:01 AM | Health Care Conference | |
| 18 Jun 2007 | 07:00 AM | Holding(s) in Company | |
| 04 Jun 2007 | 07:01 AM | Phase II Trovax data at ASCO | |
| 31 May 2007 | 05:38 PM | Total Voting Rights Update | |
| 29 May 2007 | 07:01 AM | ASCO data | |
| 24 May 2007 | 07:01 AM | FBR Growth Conference | |
| 22 May 2007 | 03:53 PM | Holding(s) in Company | |
| 17 May 2007 | 01:23 PM | Blocklisting 6 monthly return | |
| 17 May 2007 | 07:00 AM | Phase II Date @ AAI Meeting | |
| 08 May 2007 | 07:01 AM | Development of OVA System | |
| 03 May 2007 | 11:59 AM | AGM 2007 | |
| 01 May 2007 | 07:01 AM | Preclinical data | |
| 30 Apr 2007 | 04:07 PM | TVR update | |
| 30 Apr 2007 | 04:05 PM | Holding(s) in Company | |
| 30 Apr 2007 | 07:01 AM | Director/PDMR Shareholding | |
| 17 Apr 2007 | 04:02 PM | Annual Information Update | |
| 05 Apr 2007 | 03:29 PM | Holding(s) in Company | |
| 03 Apr 2007 | 04:30 PM | Director/PDMR Shareholding | |
| 30 Mar 2007 | 02:32 PM | Total Voting Rights | |
| 29 Mar 2007 | 02:30 PM | Notice of AGM | |
| 28 Mar 2007 | 07:01 AM | Agreement to develop Trovax | |
| 20 Mar 2007 | 06:05 PM | Holding(s) in Company | |
| 16 Mar 2007 | 05:31 PM | Holding(s) in Company | |
| 16 Mar 2007 | 01:35 PM | Holding(s) in Company | |
| 15 Mar 2007 | 08:42 AM | Acquisition | |
| 12 Mar 2007 | 07:01 AM | Acq of Oxxon Therapeutics | |
| 06 Mar 2007 | 07:00 AM | Preliminary Results | |
| 28 Feb 2007 | 11:15 AM | Total Voting Rights | |
| 27 Feb 2007 | 11:12 AM | Holding(s) in Company | |
| 27 Feb 2007 | 07:00 AM | Notice of FY2006 Results | |
| 22 Feb 2007 | 09:36 AM | Holding(s) in Company | |
| 20 Feb 2007 | 12:45 PM | Holding(s) in Company | |
| 14 Feb 2007 | 11:04 AM | Holding(s) in Company | |
| 09 Feb 2007 | 10:55 AM | Holding(s) in Company | |
| 07 Feb 2007 | 05:49 PM | Holding(s) in Company |
Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.
Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.
Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.